Comparative Effectiveness of BNT162b2 versus Ad26.COV2.S for the Prevention of COVID-19 among Dialysis Patients

Steven M. Brunelli, Scott Sibbel, Steph Karpinski, Gilbert Marlowe, Adam G. Walker, Jeffrey Giullian, David Van Wyck, Tara Kelley, Rachael Lazar, Meredith L. Zywno, Jeffrey J. Connaire, Amy Young, Francesca Tentori
doi: https://doi.org/10.1101/2021.10.21.21265339

Article Information

doi 
https://doi.org/10.1101/2021.10.21.21265339
History 
  • October 25, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Steven M. Brunelli, MSCE, MD1,*,
  2. Scott Sibbel, MPH, PhD1,
  3. Steph Karpinski, MS, MA1,
  4. Gilbert Marlowe, BS1,
  5. Adam G. Walker, PhD1,
  6. Jeffrey Giullian, MD2,
  7. David Van Wyck, MD2,
  8. Tara Kelley, MBA1,
  9. Rachael Lazar, MPH2,
  10. Meredith L. Zywno, MSPH2,
  11. Jeffrey J. Connaire, MD1,
  12. Amy Young, BA1 and
  13. Francesca Tentori, MS, MD1
  1. 1DaVita Clinical Research, Minneapolis, Minnesota, USA
  2. 2DaVita Inc, Denver, Colorado, USA
  1. ↵*Corresponding author; email: steven.brunelli{at}davita.com
Back to top
Posted October 25, 2021.
Download PDF
Data/Code
Email
Comparative Effectiveness of BNT162b2 versus Ad26.COV2.S for the Prevention of COVID-19 among Dialysis Patients
Steven M. Brunelli, Scott Sibbel, Steph Karpinski, Gilbert Marlowe, Adam G. Walker, Jeffrey Giullian, David Van Wyck, Tara Kelley, Rachael Lazar, Meredith L. Zywno, Jeffrey J. Connaire, Amy Young, Francesca Tentori
medRxiv 2021.10.21.21265339; doi: https://doi.org/10.1101/2021.10.21.21265339
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area